항원성 단백질 고정화를 통한 돈단독 백신 제조방법

Cited 0 time in scopus
Metadata Downloads

Full metadata record

DC FieldValueLanguage
dc.contributor.author안정오-
dc.contributor.author홍민희-
dc.contributor.author이홍원-
dc.contributor.author김천석-
dc.contributor.author이은교-
dc.contributor.author이주환-
dc.contributor.author정준기-
dc.contributor.author김연구-
dc.contributor.author이혁원-
dc.date.accessioned2017-04-19T11:50:16Z-
dc.date.available2017-04-19T11:50:16Z-
dc.date.issued2015-07-03-
dc.identifier.other12092KR-
dc.identifier.urihttps://oak.kribb.re.kr/handle/201005/14638-
dc.description.abstract본 발명은 돈단독균(Erysipellothrix rhusiophathiae) 유래 항원성 단백질 SpaA(surface protective antigen A) 및 셀룰로오스 바인딩 도메인(CBD) 단백질이 연결된 융합 단백질을 제조하고; 상기 융합 단백질을 셀룰로오스 매트릭스에 고정화하는; 단계를 포함하는 항원성 단백질 고정화를 통한 돈단독 질병에 대한 백신 제조 방법에 대한 것이다.-
dc.publisher주식회사 중앙백신연구소ko
dc.publisher한국생명공학연구원ko
dc.relation.haspart940ko
dc.title항원성 단백질 고정화를 통한 돈단독 백신 제조방법-
dc.title.alternativeMETHOD FOR PRODUCTION OF VACCINE AGAINST SWINE ERYSIPELAS BY IMMOBILIZATION OF ANTIGENIC PROTEIN-
dc.typePatent-
dc.date.registration2015-07-03-
dc.contributor.affiliatedAuthor안정오-
dc.contributor.affiliatedAuthor홍민희-
dc.contributor.affiliatedAuthor이홍원-
dc.contributor.affiliatedAuthor김천석-
dc.contributor.affiliatedAuthor이은교-
dc.contributor.affiliatedAuthor이주환-
dc.contributor.affiliatedAuthor정준기-
dc.contributor.affiliatedAuthor김연구-
dc.contributor.affiliatedAuthor이혁원-
dc.date.application2012-12-28-
dc.identifier.patentApplicationNumber10-2012-0156944-
dc.identifier.patentRegistrationNumber10-1535704-0000-
dc.publisher.location대한민국-
dc.contributor.assignee(주)중앙백신연구소,한국생명공학연구원-
dc.contributor.inventor안정오-
dc.description.patentCountryDivision국내-
Appears in Collections:
Division of Bio Technology Innovation > BioProcess Engineering Center > 2. Patents
Division of Bio Technology Innovation > 2. Patents
Division of A.I. & Biomedical Research > Biotherapeutics Translational Research Center > 2. Patents
Files in This Item:
  • There are no files associated with this item.


Items in OpenAccess@KRIBB are protected by copyright, with all rights reserved, unless otherwise indicated.